Stewart Jeffrey Ryan (CIK 1761675) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Sell ABBV (23,812 shares), Buy ABBV (26,063 shares), Buy ABBV (9,266 shares), Buy ABBV (9,432 shares), Buy ABBV (8,988 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | AbbVie Inc. (ABBV) | EVP, CHIEF COMMERCIAL OFFICER | Sell | 23,812 | $5.5M |
| 2026-02-20 | AbbVie Inc. (ABBV) | EVP, CHIEF COMMERCIAL OFFICER | Buy | 26,063 | $0 |
| 2026-02-20 | AbbVie Inc. (ABBV) | EVP, CHIEF COMMERCIAL OFFICER | Buy | 9,266 | $0 |
| 2026-02-20 | AbbVie Inc. (ABBV) | EVP, CHIEF COMMERCIAL OFFICER | Buy | 9,432 | $0 |
| 2026-02-20 | AbbVie Inc. (ABBV) | EVP, CHIEF COMMERCIAL OFFICER | Buy | 8,988 | $0 |
| 2025-04-02 | AbbVie Inc. (ABBV) | EVP, CHIEF COMMERCIAL OFFICER | Buy | 25,700 | $2.0M |
| 2025-04-02 | AbbVie Inc. (ABBV) | EVP, CHIEF COMMERCIAL OFFICER | Sell | 25,700 | $5.4M |
| 2025-04-02 | AbbVie Inc. (ABBV) | EVP, CHIEF COMMERCIAL OFFICER | Sell | 33,132 | $7.0M |
| 2025-03-04 | AbbVie Inc. (ABBV) | EVP, CHIEF COMMERCIAL OFFICER | Sell | 20,226 | $4.1M |
| 2025-02-18 | AbbVie Inc. (ABBV) | EVP, CHIEF COMMERCIAL OFFICER | Buy | 19,111 | $0 |
| 2025-02-18 | AbbVie Inc. (ABBV) | EVP, CHIEF COMMERCIAL OFFICER | Buy | 7,840 | $0 |
| 2025-02-18 | AbbVie Inc. (ABBV) | EVP, CHIEF COMMERCIAL OFFICER | Buy | 9,268 | $0 |
| 2025-02-18 | AbbVie Inc. (ABBV) | EVP, CHIEF COMMERCIAL OFFICER | Buy | 9,432 | $0 |
Source: SEC Form 4 filings · as of 2026-03-03